Induced labor. Maternal obesity
Conditions
Interventions
Estudo experimental piloto tipo ensaio clínico randomizado aberto objetivando comparar as taxas de sucesso na maturação do colo uterino em gestantes obesas. Será obtida uma amostra consecutiva de sess
Drug
Device
Other
D10.251.355.255.550.775.450.500
D10.251.355.255.550.250.200
Sponsors
Universidade Federal da Paraiba
Hospital Universitário Lauro Wanderley
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Nulliparous or multiparous pregnant obese women; 37 weeks of gestational age; Bishop score less than or equal to 6.
Exclusion criteria
Exclusion criteria: Multiple babies; Anomalous fetal presentations; Unexplained vaginal bleeding; Abnormal Placentation: Placenta Previa, Vasa Previa or Placenta Accreta; Previous uterine scar; Active liver, kidney, lung or heart disease; systemic or local infectious diseases; allergy to any prostaglandins.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the success of cervical ripening in obese pregnant women submited to labor induction with misoprostol and dinoprostone, verified through the evaluation of Bishop score greater or equal to 6. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the time between the use of medication and appropriated cervical ripening, based on Bishop score greater or equal to 6.;Evaluate the need of complementary intravenous oxytocin during induction of labor between the groups.;Analyze the rates of cesarian births and vaginal deliveries among the groups by monitoring participants.;Evaluate other outcomes or complications during labor, such as tachysystole, meconium, dystocia and fetal distress.;Evaluate the presence of maternal side effects related to the induction method, defined as the adverse events related to drug composition, such as fever, nausea or vomiting. | — |
Countries
Brazil
Contacts
Public ContactMarcela;Sofia Freire;Miranda
Universidade Federal da Paraiba;Hospital Universitário Lauro Wanderley
Outcome results
None listed